Background: With global dementia prevalence estimated to reach 139 million by 2050, early detection of dementia-causing diseases is crucial for promoting preventative interventions. Wearable technologies have the potential to detect early signs; however, they need to be acceptable amongst users. We explored user's perspectives on the acceptability of wearable devices.
View Article and Find Full Text PDFBackground: With global dementia prevalence estimated to reach 139 million by 2050,(1) early detection of dementia-causing diseases is crucial for promoting preventative interventions. Wearable technologies have the potential to detect early signs; however, they need to be acceptable amongst users. We explored user's perspectives on the acceptability of wearable devices.
View Article and Find Full Text PDFBackground: Health anxiety is an under-recognised but frequent cause of distress that is potentially treatable, but there are few studies in secondary care.
Objective: To determine the clinical effectiveness and cost-effectiveness of a modified form of cognitive-behaviour therapy (CBT) for health anxiety (CBT-HA) compared with standard care in medical outpatients.
Design: Randomised controlled trial.
Objectives: To determine the prevalence of significant health anxiety (hypochondriasis) in patients aged 16-75 in cardiology, respiratory medicine, neurological, endocrine and gastrointestinal clinics in general hospitals in London, Middlesex and North Nottinghamshire.
Method: The Health Anxiety Inventory (HAI) (short form) was administered to patients attending the five clinics over a 21 month period and all those who scored 20 or more invited to take part in a further assessment for a randomised controlled trial.
Results: Of 43,205 patients attending the clinics 28,991 (67.